Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

Phase 4 Completed 104 enrolled University of Texas Southwestern Medical Center Scios, Inc. · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if an 8hr infusion of nesiritide in the emergency department in the Acutely decompensated heart failure patients will decrease 30 day recidivism.

Timeline

Start: 2003-12
Primary completion: —
Completion: 2005-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Nesiritide	Protein / enzyme biologic	0.01 ug/kg	Intravenous

Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

Summary

Timeline

Drugs

Indications